Epalrestat
Numru CAS ta '82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat jintuża biex jipprevjeni, itejjeb u jikkura newropatija periferali (tnemnim, uġigħ), parestesija vibratorja, u anormalità kardijaka assoċjata mad-dijabete. SPEĊIFIKAZZJONI
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat jintuża biex jipprevjeni, itejjeb u jikkura newropatija periferali (tnemnim, uġigħ), parestesija vibratorja, u anormalità kardijaka assoċjata mad-dijabete. SPEĊIFIKAZZJONI
P isem roduct | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Ikteb il-messaġġ tiegħek hawn u ibagħtilna